Biogen Inc.
BIIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,632,200 | $1,161,500 | $2,961,600 | $1,727,600 |
| Dep. & Amort. | $673,200 | $494,800 | $518,400 | $487,700 |
| Deferred Tax | -$158,100 | -$305,800 | -$168,600 | -$426,800 |
| Stock-Based Comp. | $291,200 | $264,200 | $254,100 | $238,600 |
| Change in WC | -$155,200 | -$648,700 | -$890,300 | -$145,500 |
| Other Non-Cash | $592,200 | $581,200 | -$1,290,900 | $1,758,300 |
| Operating Cash Flow | $2,875,500 | $1,547,200 | $1,384,300 | $3,639,900 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$359,800 | -$311,400 | -$243,200 | -$294,900 |
| Net Acquisitions | -$1,074,800 | -$6,913,800 | $595,000 | $28,100 |
| Inv. Purchases | $0 | -$5,140,700 | -$3,448,500 | -$3,808,700 |
| Inv. Sales/Matur. | $551,500 | $8,288,500 | $4,661,300 | $3,498,900 |
| Other Inv. Act. | $83,900 | -$11,300 | $24,400 | $12,900 |
| Investing Cash Flow | -$799,200 | -$4,088,700 | $1,589,000 | -$563,700 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$650,000 | $187,300 | -$1,002,200 | -$170,000 |
| Stock Issued | -$31,300 | -$44,300 | -$1,900 | -$700 |
| Stock Repurch. | $0 | $0 | -$750,000 | -$1,800,000 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,200 | -$6,000 | -$5,600 | -$115,500 |
| Financing Cash Flow | -$683,500 | $137,000 | -$1,759,700 | -$2,086,200 |
| Forex Effect | -$67,700 | $35,100 | -$55,700 | -$59,800 |
| Net Chg. in Cash | $1,325,100 | -$2,369,400 | $1,157,900 | $930,200 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,049,900 | $3,419,300 | $2,261,400 | $1,331,200 |
| End Cash | $2,375,000 | $1,049,900 | $3,419,300 | $2,261,400 |
| Free Cash Flow | $2,515,700 | $1,235,800 | $1,144,000 | $3,381,800 |